The partnership will develop a diagnostic blood test for breast cancer. Credit: National Cancer Institute on Unsplash.

Researchers from Australia’s University of Sydney have collaborated with BCAL Diagnostics for the development of a diagnostic blood test for early detection of breast cancer.

The university’s Faculty of Medicine and Health researchers are working with BCAL to transform the diagnosis of breast cancer.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Since 2017, Sydney Mass Spectrometry (SydneyMS) and the Charles Perkins Centre were working with BCAL. SydneyMS is a core research facility based at the Kolling Institute.

BCAL scientists utilised SydneyMS’ technology to discover novel lipid biomarkers for breast cancer through liquid chromatography-mass spectrometry.

Different members of the Faculty of Medicine and Health’s Sydney Medical School and School of Medical Sciences have been working with BCAL to develop the test.

Professor Lisa Horvath from the Sydney Medical School is focused on developing the test and conducting talks for clinical trials.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Dr Kim Alexander from the School of Medical Sciences is engaged in ongoing discussions and partnerships on lipids and brain cancer samples.

BCAL chief scientific officer Dr Amani Batarseh and Sydney Medical School’s Dr Dinny Graham are working together to collect samples out of Westmead.

Sydney Medical School’s associate professor Sanjay Warrier, along with Dr Batarseh, is involved in the collection of samples at Lifehouse.

Dr Batarseh said: “The partnership with the University of Sydney had impacted the project on many levels.

“From informal discussions with researchers like Dr Anthony Don on untargeted lipidomics to engagement with Dr Kim Alexander that could lead to new avenues of research on lipids and brain cancer.”

The blood test is anticipated to be accredited and launched by next year.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact